Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tanja K. Froehlich
Observed names:
Froehlich, Tanja K.,
T K Froehlich,
T. Froehlich,
T. K. Froehlich,
Tanja K Froehlich
Observed institutions:
University of Bern,
University Hospital of Bern
OpenAlex ID:
A5070917146
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data
2015
·
Didier Meulendijks
, Linda M Henricks
, et al.
·
The Lancet Oncology
·
383
PDF
Dihydropyrimidine Dehydrogenase Gene as a Major Predictor of Severe 5-Fluorouracil Toxicity
2011
·
Ursula Amstutz
, Tanja K Froehlich
, et al.
·
Pharmacogenomics
·
217
Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early‐onset fluoropyrimidine toxicity
2014
·
Tanja K. Froehlich
, Ursula Amstutz
, et al.
·
International Journal of Cancer
·
147
PDF
Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study
2012
·
F. Mueller
, B. Büchel
, et al.
·
Cancer Chemotherapy and Pharmacology
·
103
PDF
Predicting 5-Fluorouracil Toxicity: DPD Genotype and 5,6-Dihydrouracil: Uracil Ratio
2014
·
Johanna Sistonen
, Barbara Büchel
, et al.
·
Pharmacogenomics
·
64
Accuracy of serological testing for SARS‐CoV‐2 antibodies: First results of a large mixed‐method evaluation study
2020
·
Daniel Brigger
, Michael P. Horn
, et al.
·
Allergy
·
34
PDF
Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine‐associated toxicity
2016
·
Didier Meulendijks
, Linda M. Henricks
, et al.
·
International Journal of Cancer
·
34
Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis
2019
·
Seid Hamzic
, Dominic Kummer
, et al.
·
Pharmacological Research
·
29
PDF
Serological testing for SARS‐CoV‐2 antibodies in clinical practice: A comparative diagnostic accuracy study
2022
·
Michael P. Horn
, Hulda R. Jonsdottir
, et al.
·
Allergy
·
18
PDF
Dihydropyrimidinase and β-Ureidopropionase Gene Variation and Severe Fluoropyrimidine-Related Toxicity
2015
·
Dominic Kummer
, Tanja K Froehlich
, et al.
·
Pharmacogenomics
·
14
A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies
2020
·
Dominic Schaerer
, Tanja K. Froehlich
, et al.
·
Journal of Personalized Medicine
·
10
PDF
Haplotyping of TNFα gene promoter using melting temperature analysis: detection of a novel –856(G/A) mutation
2005
·
Y. Song
, J. Araki
, et al.
·
Tissue Antigens
·
8
The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicity
2016
·
S Hamzic
, N Wenger
, et al.
·
The Pharmacogenomics Journal
·
3
Abstract 5805: Novel approach to thymidylate synthase genotype determination and utility as a biomarker of severe toxicity to 5-FU chemotherapy
2022
·
Huixing Huang
, Dominic Schaerer
, et al.
·
Cancer Research
Serological Testing for COVID-19 (SARS-CoV-2): Initial Assessment of Various Approaches in a Large Mixed-Method Diagnostic Accuracy Study
2020
·
Daniel Brigger
, Michael P. Horn
, et al.
·
SSRN Electronic Journal
Verifying Protective Immunity Against SARS-CoV-2: Assessment of Serological Antibody Tests in a Mixed-Method Diagnostic Accuracy Study
2020
·
Daniel Brigger
, Michael P. Horn
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
18
Citation count:
1,066
H-index:
10
I10-index:
11
Year
Topic
Type
